# Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

> **NCT04065906** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Neurofeedback
- Attention Deficit Hyperactivity Disorder (ADHD)

## Interventions

- **BEHAVIORAL:** NIRS neurofeedback
- **DRUG:** Methylphenidate or Tomoxetine

## Key facts

- **NCT ID:** NCT04065906
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-15
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065906, "Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04065906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*